Paradigm for Next-Generation Beneficial Microorganisms Akk

Product Details
Customization: Available
CAS No.: N
Formula: N
Still deciding? Get samples of US$ 100/Bag
Request Sample

360° Virtual Tour

Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Flexible Customization
The supplier provides Flexible customization services for your Personalized requirements
ODM Services
The supplier provides ODM services
R&D Capabilities
The supplier has 1 R&D engineers, you can check the Audit Report for more information
to see all verified strength labels (22)
  • Paradigm for Next-Generation Beneficial Microorganisms Akk
  • Paradigm for Next-Generation Beneficial Microorganisms Akk
  • Paradigm for Next-Generation Beneficial Microorganisms Akk
  • Paradigm for Next-Generation Beneficial Microorganisms Akk
  • Paradigm for Next-Generation Beneficial Microorganisms Akk
  • Paradigm for Next-Generation Beneficial Microorganisms Akk
Find Similar Products

Basic Info.

Model NO.
AMP018
EINECS
N
Packaging Material
Plastic
Storage Method
Normal
Shelf Life
>12 Months
Nutrient Composition
Protein
Resource
Natural
The content of active substances
31%~60%
Appearance
Dry Powder
Smell
Addible
Density
From 5b-100b/G
Transport Package
Bagged
Specification
TBC
Trademark
N
Origin
China
HS Code
21069090
Production Capacity
500kg/M

Product Description

Introduction

As a mucin utilizing specialist1, Akkermansia muciniphila has been highly considered as one of the next-generation probiotics (NGPs) and is regarded to play an important role in the maintenance of the intestinal epithelial barrier. A typical cycle of intestinal inflammation is driven by abnormal interactions among genetic risk factors, environmental triggers (microbiota), modifiers, and the host's immune system. Akkermansia muciniphila widely exists in the GIT of multiple animals including humans, mice, cattle, guinea pigs, swine, rabbits, ostriches and chickens. In infants and healthy adults, A. muciniphila can account for 1~3% of total fecal cells, during which the excessive degradation of mucin allows pathogens to invade the sloughed intestinal mucosa. In such cases, supplement with adequate numbers of A. muciniphila, or heat-killed A. muciniphila may safely improve the intestinal barrier in obese humans and mice fed high-fat diets. However, an excessive enrichment of A. muciniphila in mice with a specific intestinal environment may lead to the aggravation of intestinal inflammation caused by epithelial barrier damage. Although the effect of A. muciniphila on intestinal inflammation has been gradually studied, how it works is still unclear. Meanwhile, factors including host, intestinal segmentation, age, intestinal disease, and diet, affecting the distribution of A. muciniphila in the GIT and how A. muciniphila interacts with the host to maintain intestinal health is mainly unknown. 
Paradigm for Next-Generation Beneficial Microorganisms AkkParadigm for Next-Generation Beneficial Microorganisms AkkParadigm for Next-Generation Beneficial Microorganisms AkkParadigm for Next-Generation Beneficial Microorganisms AkkDosage
 Follow your physician's guidance or instructions enclosed. 
Storage
 
Keep dry in dark.
More.
Paradigm for Next-Generation Beneficial Microorganisms AkkParadigm for Next-Generation Beneficial Microorganisms AkkParadigm for Next-Generation Beneficial Microorganisms AkkParadigm for Next-Generation Beneficial Microorganisms Akk

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier